|
1
|
Shi Q, Rafli S, Wu MH, Wijelath ES, Yu C,
Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, et al: Evidence
for circulating bone marrow-derived endothelial cells. Blood.
92:362–367. 1998.PubMed/NCBI
|
|
2
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: ‘Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization’. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Werner N and Nickenig G: Influence of
cardiovascular risk factors on endothelial progenitor cells:
Limitations for therapy? Arterioscler Thromb Vasc Biol. 26:257–266.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thum T and Bauersachs J: Endothelial
progenitor cells as potential drug targets. Curr Drug Targets
Cardiovasc Haematol Disord. 5:277–286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agarwal B and Baur JA: Resveratrol and
life extension. Ann N Y Acad Sci. 1215:138–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borriello A, Bencivenga D, Caldarelli I,
Tramontano A, Borgia A, Zappia V and Ragione F Della: Resveratrol:
From basic studies to bedside. Cancer Treat Res. 159:167–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marques FZ, Markus MA and Morris BJ:
Resveratrol: Cellular actions of a potent natural chemical that
confers a diversity of health benefits. Int J Biochem Cell Biol.
41:2125–2128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xia L, Wang XX, Hu XS, Guo XG, Shang YP,
Chen HJ, Zeng CL, Zhang FR and Chen JZ: Resveratrol reduces
endothelial progenitor cells senescence through augmentation of
telomerase activity by Akt-dependent mechanisms. Br J Pharmacol.
155:387–394. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng H, Fu G, Dai T and Huang H:
Migration of endothelial progenitor cells mediated by stromal
cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal
transduction pathway. J Cardiovasc Pharmacol. 50:274–280. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng H, Dai T, Zhou B, Zhu J, Huang H,
Wang M and Fu G: SDF-1alpha/CXCR4 decreases endothelial progenitor
cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway.
Atherosclerosis. 201:36–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Assmus B, Urbich C, Aicher A, Hofmann WK,
Haendeler J, Rössig L, Spyridopoulos I, Zeiher AM and Dimmeler S:
HMG-CoA reductase inhibitors reduce senescence and increase
proliferation of endothelial progenitor cells via regulation of
cell cycle regulatory genes. Circ Res. 92:1049–1055. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lindner V, Fingerle J and Reidy MA: Mouse
model of arterial injury. Circ Res. 73:792–796. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Opie LH and Lecour S: The red wine
hypothesis: From concepts to protective signalling molecules. Eur
Heart J. 28:1683–1693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XB, Huang J, Zou JG, Su EB, Shan QJ,
Yang ZJ and Cao KJ: Effects of resveratrol on number and activity
of endothelial progenitor cells from human peripheral blood. Clin
Exp Pharmacol Physiol. 34:1109–1115. 2007.PubMed/NCBI
|
|
15
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI
|
|
16
|
Wang Q, Li H, Wang XW, Wu DC, Chen XY and
Liu J: Resveratrol promotes differentiation and induces
Fas-independent apoptosis of human medulloblastoma cells. Neurosci
Lett. 351:83–86. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delmas D, Rébé C, Lacour S, Filomenko R,
Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L,
Latruffe N and Solary E: Resveratrol-induced apoptosis isassociated
with Fas redistribution in the rafts and the formation of a
death-inducing signaling complex in colon cancer cells. J Biol
Chem. 278:41482–41490. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bernhard D, Tinhofer I, Tonko M, Hübl H,
Ausserlechner MJ, Greil R, Kofler R and Csordas A: Resveratrol
causes arrest in the S-phase prior to Fas-independent apoptosis in
CEM-C7H2 acute leukemia cells. Cell Death Differ. 7:834–842. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dörrie J, Gerauer H, Wachter Y and Zunino
SJ: Resveratrol induces extensive apoptosis by depolarizing
mitochondrial membranes and activating caspase-9 in acute
lymphoblastic leukemia cells. Cancer Res. 61:4731–4739.
2001.PubMed/NCBI
|
|
20
|
Borriello A, Bencivenga D, Caldarelli I,
Tramontano A, Borgia A, Zappia V and Ragione F Della: Resveratrol:
From basic studies to bedside. Cancer Treat Res. 159:167–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balestrieri ML, Schiano C, Felice F,
Casamassimi A, Balestrieri A, Milone L, Servillo L and Napoli C:
Effect of low doses of red wine and pure resveratrol on circulating
endothelial progenitor cells. J Biochem. 143:179–186. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia L, Wang XX, Hu XS, Guo XG, Shang YP,
Chen HJ, Zeng CL, Zhang FR and Chen JZ: Resveratrol reduces
endothelial progenitor cells senescence through augmentation of
telomerase activity by Akt-dependent mechanisms. Br J Pharmacol.
155:387–394. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Imanishi T, Hano T, Sawamura T and Nishio
I: Oxidized low-density lipoprotein induces endothelial progenitor
cell senescence, leading to cellular dysfunction. Clin Exp
Pharmacol Physiol. 31:407–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Imanishi T, Hano T and Nishio I:
Angiotensin II accelerates endothelial progenitor cell senescence
through induction of oxidative stress. J Hypertens. 23:97–104.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao XM, Wu CF and Lu GP: Atorvastatin
inhibits homocysteine-induced oxidative stress and apoptosis in
endothelial progenitor cells involving Nox4 and p38MAPK.
Atherosclerosis. 210:114–121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sorrentino SA, Bahlmann FH, Besler C,
Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A,
Limbourg F, et al: Oxidant stress impairs in vivo
reendothelialization capacity of endothelial progenitor cells from
patients with type 2 diabetes mellitus: Restoration by the
peroxisome proliferator-activated receptor-gamma agonist
rosiglitazone. Circulation. 116:163–173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carluccio MA, Ancora MA, Massaro M,
Carluccio M, Scoditti E, Distante A, Storelli C and De Caterina R:
Homocysteine induces VCAM-1 gene expression through NF-kappaB and
NAD(P)H oxidase activation: protective role of Mediterranean diet
polyphenolic antioxidants. Am J Physiol Heart Circ Physiol.
293:H2344–H2354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Zhang J, Ungvari Z and Zhang C:
Resveratrol improves endothelial function: Role of TNF{alpha} and
vascular oxidative stress. Arterioscler Thromb Vasc Biol.
29:1164–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Werner C, Kamani CH, Gensch C, Böhm M and
Laufs U: The peroxisome proliferator-activated receptor-gamma
agonist pioglitazone increases number and function of endothelial
progenitor cells in patients with coronary artery disease and
normal glucose tolerance. Diabetes. 56:2609–2615. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Imanishi T, Kobayashi K, Kuroi A, Ikejima
H and Akasaka T: Pioglitazone inhibits angiotensin II-induced
senescence of endothelial progenitor cell. Hypertens Res.
31:757–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Honda A, Matsuura K, Fukushima N, Tsurumi
Y, Kasanuki H and Hagiwara N: Telmisartan induces proliferation of
human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt
pathway. Atherosclerosis. 205:376–384. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krönke G, Kadl A, Ikonomu E, Blüml S,
Fürnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR and
Leitinger N: Expression of heme oxygenase-1 in human vascular cells
is regulated by peroxisome proliferator-activated receptors.
Arterioscler Thromb Vasc Biol. 27:1276–1282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abraham NG and Kappas A: Pharmacological
and clinical aspects of heme oxygenase. Pharmacol Rev. 60:79–127.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kruger AL, Peterson SJ, Schwartzman ML,
Fusco H, McClung JA, Weiss M, Shenouda S, Goodman AI, Goligorsky
MS, Kappas A and Abraham NG: Up-regulation of heme oxygenase
provides vascular protection in an animal model of diabetes through
its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther.
319:1144–1152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thirunavukkarasu M, Penumathsa SV, Koneru
S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK and Maulik N:
Resveratrol alleviates cardiac dysfunction in
streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin,
and heme oxygenase. Free Radic Biol Med. 43:720–729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Das S, Fraga CG and Das DK:
Cardioprotective effect of resveratrol via HO-1 expression involves
p38 map kinase and PI-3-kinase signaling, but does not involve
NFkappaB. Free Radic Res. 40:1066–1075. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Deshane J, Chen S, Caballero S,
Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B,
Hill-Kapturczak N, et al: Stromal cell-derived factor 1 promotes
angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med.
204:605–618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu BJ, Midwinter RG, Cassano C, Beck K,
Wang Y, Changsiri D, Gamble JR and Stocker R: Heme oxygenase-1
increases endothelial progenitor cells. Arterioscler Thromb Vasc
Biol. 29:1537–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
